Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Figitumumab in Recurrent/Metastatic Head and Neck Cancer
NCT00872404Phase 2Terminated
- Start
- Jan 2009
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of figitumumab in head and neck squamous cell carcinoma (HNSCC). Started Jan 2009; status: terminated.
02
Drugs
figitumumab
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00872404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872404.